Overview
Meihuan Chen practices in Fuzhou, China. Chen is rated as an Advanced expert by MediFind in the treatment of Hemolytic Anemia. Their top areas of expertise are Beta Thalassemia, Thalassemia, Alpha Thalassemia, and Hemoglobinopathy.
Their clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 25 articles in the study of Hemolytic Anemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Alpha ThalassemiaChen isDistinguished. Learn about Alpha Thalassemia.
- Beta ThalassemiaChen isDistinguished. Learn about Beta Thalassemia.
- ThalassemiaChen isDistinguished. Learn about Thalassemia.
- Advanced
- AnemiaChen isAdvanced. Learn about Anemia.
- Congenital Hemolytic Anemia
- HemoglobinopathyChen isAdvanced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaChen isAdvanced. Learn about Hemolytic Anemia.
- Experienced
- Chromosome 13q DuplicationChen isExperienced. Learn about Chromosome 13q Duplication.
- Familial DeafnessChen isExperienced. Learn about Familial Deafness.
- Fetal EdemaChen isExperienced. Learn about Fetal Edema.
- Hearing LossChen isExperienced. Learn about Hearing Loss.
- Hemolytic Disease of the Newborn
- Hydrops FetalisChen isExperienced. Learn about Hydrops Fetalis.